Mutations of PI3K, especially p110α encoded by PIK3CA, and mutation/loss of PTEN, are frequently observed in cancer broadly [74] and have been shown to activate PI3K/Akt to promote cell proliferation and prevent cell death [75], causing cancer cells to become resistant to treatment by chemotherapy [76]. The gene discussed is AKT1; the disease is cancer.